Anti-CD30 Human IL-2 Fusion Proteins Display Strong and Specific Cytotoxicity In Vivo

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|10|2|110-117

ISSN： 1389-4501

Source： Current Drug Targets, Vol.10, Iss.2, 2009-02, pp. : 110-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cellular Association and Cytotoxicity of Doxorubicin-Loaded Immunoliposomes Targeted via Fab' Fragments of an Anti-CD74 Antibody

By Lundberg B. B.   Griffiths G.   Hansen H. J.  

Drug Delivery, Vol. 14, Iss. 3, 2007-03 ,pp. : 171-175

Informa Healthcare

Access to resources Recommend Favorite

Cellular association and cytotoxicity of anti-CD74-targeted lipid drug-carriers in B lymphoma cells

By Lundberg B.B.   Griffiths G.   Hansen H.J.  

Journal of Controlled Release, Vol. 94, Iss. 1, 2004-01 ,pp. : 155-161

Elsevier

Access to resources Recommend Favorite

Frequent expression of CD30 in extranodal NK/T‐cell lymphoma: Potential therapeutic target for anti‐CD30 antibody‐based therapy

By  

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 166-173

John Wiley & Sons Inc

Access to resources Recommend Favorite

Probing human 1 - and 2 -adrenoceptors with domain-specific fusion protein antibodies

By Jahns R.   Siegmund C.   Jahns V.   Reilander H.   Maidhof A.   Muller-Esterl W.   Lohse M.J.   Boege F.  

European Journal of Pharmacology, Vol. 334, Iss. 1, 1997-09 ,pp. : 115-126

Elsevier

Access to resources Recommend Favorite

Probing human 1 - and 2 -adrenoceptors with domain-specific fusion protein antibodies

By Jahns R.   Siegmund C.   Jahns V.   Reilander H.   Maidhof A.   Muller-Esterl W.   Lohse M.J.   Boege F.  

European Journal of Pharmacology, Vol. 316, Iss. 1, 1996-11 ,pp. : 111-121

Elsevier

Access to resources Recommend Favorite